Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease

58Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis C virus (HCV) infection becomes chronic in more than 70% of patients, leading to end stage liver disease in about 20-30% of these patients. Apart from the virus itself, host factors that modulate the immune response are likely to be involved in determining the outcome of HCV infection. Studies on the association of human leucocyte antigens (HLAs) and HCV infection have shown inconsistent results. Selection of patient subgroups may be crucial. However, any association relevant to HCV disease progression will become evident, especially in those patients with end stage liver disease. Therefore, we analysed the phenotype frequencies of HLA antigens in two groups of 69 and 39 patients with HCV induced liver cirrhosis who had received a transplant or were awaiting liver transplantation. The first group was typed serologically and compared with 331 blood and liver donors. The second group, prospectively HLA typed by a polymerase chain reaction-sequence specific oligonucleotide (PCR-SSO) procedure for HLA-DRB and DQB alleles, was compared with another 170 PCR-SSO typed and randomly selected blood donors. Decreased frequencies for HLA-DR5 and HLA-DQ3 were found in one group of patients with HCV induced liver cirrhosis compared with the control groups. In the second analysis comparing 39 patients with end stage liver cirrhosis with blood donors, we confirmed the significant decrease in HLA-DRBI*11 and HLA-DQBI*03, which corresponded to serological HLA-DR5 and HLA-DQ3 antigens, respectively. Our results show that the presence of HLA-DRB1*11 and HLA-DQB1*03 alleles is associated with a reduced risk for the development of HCV induced end stage liver disease.

References Powered by Scopus

Clinical outcomes after transfusion-associated hepatitis C

1208Citations
N/AReaders
Get full text

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

826Citations
N/AReaders
Get full text

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

688Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Natural history of chronic hepatitis C

1265Citations
N/AReaders
Get full text

The history of the "natural history" of hepatitis C (1968-2009)

210Citations
N/AReaders
Get full text

A comparative review of HLA associates with hepatitis B and C viral infections across global populations

205Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tillmann, H. L., Chen, D. F., Trautwein, C., Kliem, V., Grundey, A., Berning-Haag, A., … Manns, M. P. (2001). Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut, 48(5), 714–718. https://doi.org/10.1136/gut.48.5.714

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

58%

Professor / Associate Prof. 2

17%

Researcher 2

17%

Lecturer / Post doc 1

8%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 7

50%

Medicine and Dentistry 5

36%

Biochemistry, Genetics and Molecular Bi... 1

7%

Immunology and Microbiology 1

7%

Save time finding and organizing research with Mendeley

Sign up for free